Results 281 to 290 of about 1,472,414 (411)
Prevalence and risk factors for painful diabetic peripheral neuropathy: a systematic review and meta-analysis. [PDF]
Zhou P+7 more
europepmc +1 more source
Giant cell arteritis presenting with peripheral neuropathy
Fiona Mulcahy, L D Juby, G.N. Chandler
openalex +1 more source
Movement Disorders Clinical Practice, EarlyView.
Matthew Julian Georgiades+7 more
wiley +1 more source
ABSTRACT Objective High glucose damages rat Schwann cells (SCs), which is closely related to the dysfunction of mitochondria‐associated endoplasmic reticulum membranes (MAMs). Therefore, the present study aimed to investigate the protective effects and mechanisms of modified bone marrow mesenchymal stem cells (BMSCs) and mitochondrial fusion protein 2 (
Housheng Fu+4 more
wiley +1 more source
Potential of histone deacetylase 6 inhibitors in alleviating chemotherapy-induced peripheral neuropathy. [PDF]
Park SJ+5 more
europepmc +1 more source
Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy.
Zohaib Iqbal+8 more
semanticscholar +1 more source
Adult‐Onset Dystonia‐Parkinsonism: Do Not Forget SERAC1
Movement Disorders Clinical Practice, EarlyView.
Giulia Scacciatella+15 more
wiley +1 more source
Neuronal p38 MAPK Signaling Contributes to Cisplatin-Induced Peripheral Neuropathy. [PDF]
Goel Y+5 more
europepmc +1 more source
Absence of peripheral neuropathy in long-term lead-exposed subjects
Carsten Juul Nielsen+3 more
openalex +1 more source
ABSTRACT Background Patients with sickle cell disease (SCD) experience painful vaso‐occlusive episodes that increase with age; a subset develops chronic pain (CP). CP is usually managed with acute pain management guidelines despite evidence of ineffectiveness.
Ashwin Patel+6 more
wiley +1 more source